Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

The Motley Fool March 9, 2011 Dan Caplinger	Squeeze More Income From Your Stocks The covered call strategy is a great way to produce income in a challenging environment for income investors.
The Motley Fool June 13, 2011 Bryan Hinmon	Buy and Hold Is Dead Don't miss out on this portfolio-boosting options strategy.
The Motley Fool August 29, 2008 Brian Orelli	Can Health-Care Dividends Hold Up? As many health-care companies' share prices drop, their dividend yields have become strikingly attractive. The big question, though, is whether these dividends can hold up.
The Motley Fool December 10, 2009 Jim Royal	Double (or Even Triple!) Your Payouts A low-risk strategy to fatten your income. I've found a surrogate for fatter dividends by selectively using a specific type of option to generate bonus cash on my income-producing stocks.
The Motley Fool December 6, 2010 Bryan Hinmon	Better Than Buy and Hold Use call options to boost your returns.
The Motley Fool June 14, 2011 Alex Pape	How to Yield 14%-Plus on These Stocks No dividend? No problem. Use options to build your own.
The Motley Fool September 15, 2011 Bryan Hinmon	How to Strangle Profits From an Uncertain Market A covered strangle combines three investment positions to achieve maximum rewards from a mild upward move in a stock. It may sound complicated, but it isn't.
The Motley Fool February 20, 2010 Selena Maranjian	My Big Fat Dividends Stocks like these can plump up your portfolio. Stocks like Pfizer, Nokia, and Bristol-Myers Squibb can offer good yields.
The Motley Fool August 10, 2009 Jeff Fischer	Profit on a Flat Stock Here are two simple income-generating strategies.
The Motley Fool January 8, 2009 Jeff Fischer	5 Stocks for Strong Income Boost your returns in any market with these stocks: 3M... Johnson & Johnson... McCormick & Co. ... PepsiCo... Conoco Phillips...
The Motley Fool August 26, 2010 Jordan DiPietro	Pfizer's Dividends May Not Last Forever Pfizer, which operates in the pharmaceuticals industry, currently pays a dividend of 4.5%. But what's more important than the dividend itself is Pfizer's ability to keep that that cash rolling.
The Motley Fool June 13, 2011 Jeff Fischer	Profit As Stocks Go Nowhere Writing covered strangles is a flexible, powerful way to earn extra profits owning quality stocks.
The Motley Fool July 12, 2007 Dan Caplinger	Stay Away From Covered Calls This options strategy promises income, but at too high a price.
The Motley Fool June 15, 2006 Selena Maranjian	My Dividends Are Bigger Than Yours Your yield may be 2% when mine is a whopping 13%. Here's the secret.
The Motley Fool December 21, 2006 Ryan Fuhrmann	Dueling Fools: Merck Bear Investors, because of its recent run-up, the risk/reward tradeoff is not very compelling. There are safer, more lucrative ways to invest in the space.
The Motley Fool December 16, 2008 Brian Orelli	Pfizer Keeps the Change For the first time in decades, investors won't get a dividend increase.
The Motley Fool December 23, 2009 Brian Orelli	2009 Cheers and Jeers for Pharma Unfortunately, it was more of the latter.
The Motley Fool December 8, 2010 Bryan Hinmon	5 Manufactured High Yielders How to create a high yield on your stocks with call options.
The Motley Fool March 8, 2011 Jim Gillies	How to Create Big Income on Go-Nowhere Stocks A guide to diagonal spreads.
The Motley Fool December 13, 2011 Brian Orelli	Dividend? Buyback? Here's How to Get Both. But will there be enough to replenish the pipeline?
The Motley Fool January 26, 2011 Dan Caplinger	Get More Cash From Your Winners Long-held winning stocks create tax problems if you sell, but there's another way to draw income from them.
The Motley Fool March 9, 2011 Bryan Hinmon	How to Strangle More Profits Out of Your Winners This options strategy can boost returns from steady stocks.
The Motley Fool December 24, 2009 Dan Caplinger	The Tax-Smart Way to Lock In Gains Today A variation of the popular covered call strategy can help you preserve your stock market gains without immediately creating a taxable event.
The Motley Fool October 30, 2009 Brian Orelli	World's Scariest Stocks: Pfizer For Pfizer, the big, scary unknown comes from whether it can integrate its recent acquisition of Wyeth.
The Motley Fool January 25, 2008 Selena Maranjian	Optimizing Dividends Look for solid and growing yields -- especially when stock prices fall.
The Motley Fool February 29, 2008 Brian Orelli	2007 Pharma Roundup How did big pharma do in 2007? With the drug sector earnings season winding down, now seems like a good time to take a look at how they fared and, more importantly, where they're headed.
The Motley Fool September 12, 2011 John Rosevear	A Simple Options Strategy for Everyone Do options scare you? They scare a lot of folks. But this simple strategy boosts your profits with minimal risk. Really.
The Motley Fool January 23, 2007 Ryan Fuhrmann	Pfizer Pfizzles Through 2006 The company is in a top-line pickle, but it expects things to get better. Current investors are now left standing until a rebound in growth, now targeted for 2009.
The Motley Fool August 23, 2010 Jordan DiPietro	How Safe Are Eli Lilly's Dividends? Check out how Eli Lilly stacks up
The Motley Fool November 30, 2004 Selena Maranjian	Focus on Future Dividend Yields Dividends have their place in many, if not most, portfolios. But don't just look for companies that are paying hefty dividends today. Here are two reasons why.
The Motley Fool April 24, 2007 Jim Gillies	Options Pricing: A Beginning Which options should you buy? What strike price? What expiration date?
The Motley Fool October 30, 2009 Dan Caplinger	Should You Dump These Dividend Stocks? After the market's big rally, many stocks have seen their dividend yields drop sharply. Do those falling yields mean that you should get out of these dividend stocks now before it's too late?
The Motley Fool December 23, 2005 Nathan Parmelee	The Investing Strategy That Keeps Giving The best results from dividends require patience, a long-term time horizon, and excellent companies for your investment dollars.
The Motley Fool August 18, 2010 Jordan DiPietro	How Long Will Merck's Dividend Last? Check out how Merck stacks up in this article.
The Motley Fool November 7, 2009 Dan Caplinger	These Dividend Stocks Won't Let You Down Don't put your portfolio at risk.
The Motley Fool June 16, 2011 Alex Dumortier	Double Your Yield on These 7 Blue Chips By selling a put on a stock you own you can either double the dividend you receive on the stock, or add to your stock position at a discount to the current price.
The Motley Fool January 26, 2007 Selena Maranjian	What Dividends Tell You Dividends can tell you a lot about a company -- perhaps more than you think.
The Motley Fool May 11, 2009 Selena Maranjian	How I'm Grabbing 20% Dividend Yields While the current yield on a stock might be only 2 or 3%, for those who bought it long ago at a lower price, and who are getting that same current dividend, their effective yield is higher. And over time, it can grow very high indeed.
The Motley Fool March 23, 2011 Todd Wenning	Dividend Report Card: Pfizer Investors considering Pfizer as a dividend play should decide if the combination of 4% current yield and low- to mid-single-digit dividend growth potential is a better deal than other pharmaceutical shares are offering.
The Motley Fool February 22, 2007 Ryan Fuhrmann	Dueling Fools: Pfizer Bull The drug giant has ample firepower. The current company valuation largely ignores Pfizer's upside potential past 2008.
The Motley Fool January 10, 2007 John Reeves	Is Your Stock a Dog? A dividend yield can be a very misleading ratio, and when it comes to identifying stable companies that deliver regular and growing cash flows, you must look deeper than just a single metric.
The Motley Fool March 9, 2011 Jim Gillies	A Long-Term Investor's Approach to Big Profits Covered calls are a popular, and deceptively simple, option strategy. Done correctly, you can generate income on a stock you own -- and do so over and over again to keep the cash flowing.
The Motley Fool January 19, 2007 Ryan Fuhrmann	The Best Drug Stock for 2007: Pfizer Investors, this is a great company at a great price.
The Motley Fool December 20, 2006 Selena Maranjian	Buy Tomorrow's Big Yields Today Before it's too late, snap up a future 20% yield. The key is finding companies that have the fiscal strength to raise their dividend year after year. And they're out there.
The Motley Fool December 14, 2005 Steven Mallas	Pfizer: Of Drugs and Dividends Pfizer is raising its payout. Is it a good move for the drugmaker? Investors willing to hold for years while reinvesting dividends will most likely be rewarded along the way.
The Motley Fool January 22, 2009 Todd Wenning	10 Dividend Stocks for the Next Decade and Beyond Following the worst stock market year since the Great Depression, it's natural for investors to seek more stable and less stressful stock strategies. Dividend-paying stocks provide you with an opportunity to achieve both.
The Motley Fool December 18, 2008 Brian Orelli	Best Stock for 2009: Pfizer Pfizer's languishing stock price has made the company so much more attractive; it could see a breakout in 2009.
The Motley Fool November 23, 2009 Dan Caplinger	Are These Dividends Too Good to Be True? Lots of high-yielding stocks won't last. Look for history and earnings.
The Motley Fool March 31, 2011 Todd Wenning	Dividend Sector Review: Pharmaceuticals These pharmaceutical stocks generate an adequate amount of free cash flow to fund their well above-average dividend yields.
The Motley Fool September 30, 2010 Morgan Housel	Dividend Mania What today's fascination with dividends tells us about investors.